Home › Funds › Morgan Creek Capital Management, LLC › ACAD
Morgan Creek Capital Management, LLC position in ACAD
ACADIA PHARMACEUTICALS INC · Health Care
Morgan Creek Capital Management, LLC reported holding 9,395 shares of ACAD (ACADIA PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$238K, representing 0.16% of its reported portfolio and ranking #9 among its reported holdings. Morgan Creek Capital Management, LLC first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Morgan Creek Capital Management, LLC's ACAD position evolved
Morgan Creek Capital Management, LLC first disclosed a stake in ACAD in Q2 2026 at 9,395 shares (US$238K).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 9.39K | $237.69K | New |
About ACAD and 13F data
ACAD (ACADIA PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in ACAD — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.09B), RTW INVESTMENTS, LP (US$180.8M), Palo Alto Investors LP (US$72.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ACAD
- BAKER BROS. ADVISORS LP 42.91M sh · $1.09B · Q2 2026
- RTW INVESTMENTS, LP 7.14M sh · $180.76M · Q2 2026
- Palo Alto Investors LP 2.86M sh · $72.46M · Q2 2026
- BRAIDWELL LP 1.65M sh · $41.65M · Q2 2026
- Frazier Life Sciences Management, L.P. 1.44M sh · $36.39M · Q2 2026
More on Morgan Creek Capital Management, LLC
FAQ
How long has Morgan Creek Capital Management, LLC held ACAD?
Morgan Creek Capital Management, LLC has disclosed ACAD holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Morgan Creek Capital Management, LLC's current position in ACAD?
As of Q2 2026, Morgan Creek Capital Management, LLC holds 9.39K shares of ACAD (ACADIA PHARMACEUTICALS INC), valued at $237.69K, representing 0.16% of its reported portfolio and ranking #9.
Has Morgan Creek Capital Management, LLC been buying or selling ACAD?
In the latest 13F filing (Q2 2026), Morgan Creek Capital Management, LLC newly opened its position in ACAD.
Which other funds hold ACAD?
Other major institutional holders of ACAD include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Palo Alto Investors LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.